“…For each study, PJK incidence, Revision Rate for PJK (RR), PJF incidence, reported clinical outcomes and complications were reported in Table 3. Twelve of the included studies reported on PJK incidence, 28-31,33-36,38,39,41,43 10 on revision rate for PJK, 28-31,33,35,36,38,39,41 13 on PJF incidence, 29,32,34-40,42-45 5 on any clinical outcome measure 28,38,40,41,45 and 10 on complications. 28-30,35-39,41,45 Four studies 28-30,37,45 did not elaborate on the type of complications, and could thus not be converted to the classification of Glassman et al 27 If reported, the clinical outcome measures were further elucidated in Table 4.…”